Samjin Pharmaceutical Co Ltd
KRX:005500
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of Samjin Pharmaceutical Co Ltd (005500) under the Base Case is KRW per share. Compared with the current market price of 19 810 KRW, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Samjin Pharmaceutical Does
Samjin Pharmaceutical is a South Korean drug maker that develops, manufactures, and sells medicines for people. Its products include prescription drugs and over-the-counter medicines, with a strong focus on practical treatments used by hospitals, clinics, pharmacies, and distributors in the domestic market. The company earns money mainly by selling these finished medicines under its own brands and product lines.
- Headquarters
- Korea KR
- Employees
- 755
- IPO date
- Jun 18, 1988
Revenue & Expenses Breakdown
Samjin Pharmaceutical Co Ltd
Earnings Waterfall
Samjin Pharmaceutical Co Ltd
What is the Intrinsic Value of one Samjin Pharmaceutical Co Ltd stock?
The intrinsic value for Samjin Pharmaceutical Co Ltd (005500) under the Base Case is KRW.
Is Samjin Pharmaceutical Co Ltd stock undervalued or overvalued?
Compared with the current market price of 19 810 KRW, the stock appears .